3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Lung Neoplasms
6
Neoplasms
4
Colonic Neoplasms
3
Prostatic Neoplasms
2
Patient Satisfaction
2
Ovarian Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Tuberculosis, Pulmonary
1
Thoracic Diseases
1
Supratentorial Neoplasms
1
Stomach Ulcer
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Polyps
1
Pituitary Neoplasms
1
Pain, Postoperative
1
Pain
1
Overweight
1
Obesity
1
Neurofibromatoses
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hypoxia
1
Interventions
Bismuth
6
Esomeprazole
5
Amoxicillin
5
Tetracycline
4
Oxaliplatin
4
apatinib
3
Irinotecan
3
Furazolidone
3
Fluorouracil
3
Clarithromycin
3
fish oil triglycerides
2
Rabeprazole
2
Leucovorin
2
Indocyanine Green
2
Berberine
2
sintilimab
1
potassium oxonate
1
lenvatinib
1
iron isomaltoside 1000
1
ilaprazole
1
gimeracil
1
ferric carboxymaltose
1
doxifluridine
1
alanylglutamine
1
Water
1
Trastuzumab
1
Tranexamic Acid
1
Tobacco Use Cessation Devices
1
Thalidomide
1
Tegafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Stomach Neoplasms
×
Propofol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled